Novo Holdings Leads USD125m Series C for Singapore’s Hummingbird Bioscience

Novo Holdings led a USD125m Series C for Hummingbird Bioscience, a Singapore- and US-based clinical stage developer of targeted therapeutics, with participation from Frazier Healthcare Partners, Octagon Capital, EDBI, AMGEN Ventures, DROIA Ventures, Morningside Ventures, Pureos Bioventures, Polaris Partners, Affinity Asset Advisors, Ally Bridge Group and Altrium Capital Management, and… Read More

Ascent Reaches USD100m+ First Close for East Africa Fund

Ascent has reached a USD100m+ first close for Ascent Rift Valley Fund II. The vehicle has an initial target of USD120m and plans to invest in SMEs in the financial services, manufacturing, wholesale and retail trade and services, education, healthcare and agro-processing sectors in Eastern Africa. Read… Read More



(default archive template)